TREACE MEDICAL CONCEPTS, INC. (TMCI) › Cash & EquivalentsTREACE MEDICAL CONCEPTS, INC. (TMCI) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2018: $1.28M2019: $12.14M2020: $18.08M2021: $105.83M2022: $19.47M2023: $12.98M2024: $11.35M2025: $10.71M$10.71M2018Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$10.71M-5.7%2024$11.35M-12.6%2023$12.98M-33.3%2022$19.47M-81.6%2021$105.83M+485.4%2020$18.08M+48.9%2019$12.14M+845.4%2018$1.28M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share